A Higher Dosage of Oral Alendronate Will Increase the Subsequent Cancer Risk of Osteoporosis Patients in Taiwan: A Population-Based Cohort Study

Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/47797

Title:	A Higher Dosage of Oral Alendronate Will Increase the Subsequent Cancer Risk of Osteoporosis Patients in Taiwan: A Population-Based Cohort Study
Authors:	(Wen-Yuan Lee);(Li-Min Sun);(Ming-Chia Lin);梁基安(Ji-An Liang);張仕妮(Shih-Ni Chang);宋鴻樟(Fung-Chang Sung);莫之欣;高嘉鴻(Chia-Hung Kao)*
Contributors:	醫學院醫學系學士班核子醫學科;中國附醫核子醫學科
Keywords:	Alendronate;Osteoporosis;subsequent cancer risk
Date:	2012-12
Issue Date:	2013-02-06 16:09:31 (UTC+8)
Relation:	PLoS One 7(12):e53032-e53032
Appears in Collections:	[School of Medicine] Journal articles

Files in This Item:

File	Description	Size	Format
AA-AA00_20130102084556.doc		64Kb	Microsoft Word	188	View/Open